- Home
- DJTWW vs APLS Comparison
DJTWW vs APLS Comparison
Compare DJTWW & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJTWW
- APLS
- Stock Information
- Founded
- DJTWW 2021
- APLS 2009
- Country
- DJTWW United States
- APLS United States
- Employees
- DJTWW N/A
- APLS N/A
- Industry
- DJTWW Computer Software: Programming Data Processing
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- DJTWW Technology
- APLS Health Care
- Exchange
- DJTWW Nasdaq
- APLS Nasdaq
- Market Cap
- DJTWW 4.3B
- APLS 3.6B
- IPO Year
- DJTWW N/A
- APLS 2017
- Fundamental
- Price
- DJTWW $17.78
- APLS $27.52
- Analyst Decision
- DJTWW
- APLS Buy
- Analyst Count
- DJTWW 0
- APLS 18
- Target Price
- DJTWW N/A
- APLS $46.71
- AVG Volume (30 Days)
- DJTWW 172.0K
- APLS 1.5M
- Earning Date
- DJTWW 04-02-2025
- APLS 02-28-2025
- Dividend Yield
- DJTWW N/A
- APLS N/A
- EPS Growth
- DJTWW N/A
- APLS N/A
- EPS
- DJTWW N/A
- APLS N/A
- Revenue
- DJTWW $3,369,800.00
- APLS $715,216,000.00
- Revenue This Year
- DJTWW N/A
- APLS $97.25
- Revenue Next Year
- DJTWW N/A
- APLS $12.68
- P/E Ratio
- DJTWW N/A
- APLS N/A
- Revenue Growth
- DJTWW N/A
- APLS 162.10
- 52 Week Low
- DJTWW $6.53
- APLS $24.34
- 52 Week High
- DJTWW $44.83
- APLS $71.90
- Technical
- Relative Strength Index (RSI)
- DJTWW N/A
- APLS 38.99
- Support Level
- DJTWW N/A
- APLS $26.84
- Resistance Level
- DJTWW N/A
- APLS $28.59
- Average True Range (ATR)
- DJTWW 0.00
- APLS 1.12
- MACD
- DJTWW 0.00
- APLS -0.03
- Stochastic Oscillator
- DJTWW 0.00
- APLS 18.09
About DJTWW Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest global conversation without discriminating against political ideology.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.